[SOME CLINICAL ASPECTS OF DRUG RESISTANCE OF TUBERCLE BACILLI ISOLATED FROM PATIENTS WITH FIBRO-CAVERNOUS TUBERCULOSIS].
D010131:Aminosalicylic Acid; D000636:Aminosalicylic Acids; D001407:Bacillus; D003470:Culture Media; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D006801:Humans; D007538:Isoniazid; D009169:Mycobacterium tuberculosis; D011718:Pyrazinamide; D012106:Research; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary
D000636:Aminosalicylic Acids; D003470:Culture Media; D011718:Pyrazinamide; D010131:Aminosalicylic Acid; D007538:Isoniazid
AMINOSALICYLIC ACID; CULTURE MEDIA; DRUG RESISTANCE, MICROBIAL; EXPERIMENTAL LAB STUDY; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE; TUBERCULOSIS, PULMONARY
NIAKOI KLINICHNI ASPEKTI NA LEKRASTVENATA USTO ICHNIVOST NA TUBERKULOZNITE BAKTERII, OTDELNIANI OT BOLNI OT FIBROZNO-KAVERNOZAN TUBERKULOZA.